Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/23585
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGravas, Stavros-
dc.contributor.authorFournier, Georges-
dc.contributor.authorOya, Mototsugu-
dc.contributor.authorSummerton, Duncan-
dc.contributor.authorScarpa, Roberto Mario-
dc.contributor.authorChlosta, Piotr-
dc.contributor.authorGkialas, Ioannis-
dc.contributor.authorXie, Li-Ping-
dc.contributor.authorRasyid, Nur-
dc.contributor.authorBolton, Damien M-
dc.contributor.authorGomez, Reynaldo-
dc.contributor.authorKlotz, Laurence-
dc.contributor.authorKulkarni, Sanjay-
dc.contributor.authorTanguay, Simon-
dc.contributor.authorde la Rosette, Jean-
dc.date2020-06-15-
dc.date.accessioned2020-06-30T04:09:51Z-
dc.date.available2020-06-30T04:09:51Z-
dc.date.issued2020-09-15-
dc.identifier.citationEuropean urology focus 2020; 6(5): 1104-1110en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/23585-
dc.description.abstractDetermining whether members follow guidelines, including guidelines prepared to help direct practice management during the coronavirus disease 2019 (COVID-19) pandemic, is an important goal for medical associations. To determine whether practice of urologists is in line with guidelines for the management of common urological conditions during the COVID-19 pandemic produced by leading (inter)national urological associations. Self-selected urologists completed a voluntary survey available online from March 27 to April 11, 2020 and distributed globally by the Société Internationale d'Urologie. Responses to two survey questions on the (1) management of 14 common urological procedures and (2) priority scoring of 10 common urological procedures were evaluated by practice setting and geographical region using chi-square and one-way analysis of variance analyses, respectively. There were 2494 respondents from 76 countries. Oncological conditions were prioritised over benign conditions, and benign conditions were deferred when feasible and safe. Oncological conditions with the greatest malignant potential were prioritised over less aggressive cancers. Respondents from Europe were least likely to postpone and most likely to prioritise conditions identified by guidelines as being of the highest priority. Respondents' priority scoring of urological procedures closely matched the priorities assigned by guidelines. The main limitation of this study is that respondents were self-selected, and access to the survey was limited by language and technology barriers. Prioritisation and management of urological procedures during the COVID-19 pandemic are in line with current guidelines. The greatest agreement was reported in Europe. Observed differences may be related to limited resources in some settings. When deciding how best to treat patients during the coronavirus disease 2019 (COVID-19) pandemic, urologists are taking into account both expert recommendations and the availability of important local resources.en
dc.language.isoeng-
dc.subjectCOVID-19en
dc.subjectCoronavirusen
dc.subjectGuidelinesen
dc.subjectPandemicen
dc.subjectPractice managementen
dc.subjectSevere acute respiratory syndrome coronavirus 2en
dc.subjectUrologyen
dc.titlePrioritising Urological Surgery in the COVID-19 Era: A Global Reflection on Guidelines.en
dc.typeJournal Articleen
dc.identifier.journaltitleEuropean urology focusen
dc.identifier.affiliationDepartment of Urology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greeceen
dc.identifier.affiliationDepartment of Urology, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Urology, Hopital de la Cavale Blanche, University of Brest, Brest, Franceen
dc.identifier.affiliationDepartment of Urology, Keio University School of Medicine, Tokyo, Japanen
dc.identifier.affiliationDepartment of Urology, University Hospitals of Leicester NHS Trust, Leicester, UKen
dc.identifier.affiliationDepartment of Urology, Università Campus Biomedico, Rome, Italyen
dc.identifier.affiliationDepartment of Urology, Jagiellonian University-Medical College, Krakow, Polanden
dc.identifier.affiliationDepartment of Urology, Anticancer Hospital of Athens "Agios Savvas", Athens, Greeceen
dc.identifier.affiliationDepartment of Urology, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Chinaen
dc.identifier.affiliationDepartment of Urology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo General Hospital, Jakarta, Indonesiaen
dc.identifier.affiliationUniversidad Andres Bello, Hospital del Trabajador, Santiago, Chileen
dc.identifier.affiliationDivision of Urology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canadaen
dc.identifier.affiliationKulkarni Reconstructive Urology Center, Pune, Indiaen
dc.identifier.affiliationDepartment of Surgery, Division of Urology, McGill University, Montreal, QC, Canadaen
dc.identifier.affiliationDepartment of Urology, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkeyen
dc.identifier.doi10.1016/j.euf.2020.06.006en
dc.type.contentTexten
dc.identifier.orcid0000-0002-5145-6783en
dc.identifier.pubmedid32571743-
dc.type.austinJournal Article-
local.name.researcherBolton, Damien M
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.languageiso639-1en-
crisitem.author.deptUrology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

36
checked on Feb 21, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.